Literature DB >> 22726099

Rare bleeding disorders.

Flora Peyvandi1, Paula H B Bolton-Maggs, Angelika Batorova, Philippe De Moerloose.   

Abstract

Rare bleeding disorders (RBDs) include the inherited deficiencies of fibrinogen, factor (F)II, FV, FV+FVIII, FVII, FX, FXI and FXIII. There have been remarkable advances in understanding the molecular profiles that lead to each type of coagulation factor deficiency. However, as a consequence of their rarity, clinical data regarding the characteristics of bleeding symptoms and their management remain limited. The clinical manifestations in different RBDs are heterogeneous, and the residual plasma coagulant factor level does not always predict bleeding tendency. In this review, we describe the general features and recent advances in understanding three such deficiencies: FXI, FVII and fibrinogen deficiencies.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22726099     DOI: 10.1111/j.1365-2516.2012.02841.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  7 in total

1.  Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein.

Authors:  Konstanty Szułdrzyński; Miłosz Jankowski; Daniel P Potaczek; Anetta Undas
Journal:  Dis Markers       Date:  2020-01-25       Impact factor: 3.434

2.  Anticoagulation Therapy Considerations in Factor VII Deficiency.

Authors:  Eric Paulus; Kathy Komperda; Gabriel Park; Julie Fusco
Journal:  Drug Saf Case Rep       Date:  2016-12

Review 3.  Bone Density Status in Bleeding Disorders: Where Are We and What Needs to Be Done?

Authors:  Hassan Mansouritorghabeh; Zahra Rezaieyazdi
Journal:  J Bone Metab       Date:  2017-11-30

Review 4.  Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy.

Authors:  Mariasanta Napolitano; Sergio Siragusa; Guglielmo Mariani
Journal:  J Clin Med       Date:  2017-03-28       Impact factor: 4.241

5.  Mining of mortality-related findings in rare bleeding disorders: a retrospective study from two centers.

Authors:  Hassan Rafieemehr; Akbar Dorgalaleh; Hassan Mansouritorghabeh
Journal:  Blood Res       Date:  2020-11-24

6.  A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.

Authors:  Yongliang Sun; Lingling Jia; Zhiying Yang; Wenqian Chen
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

7.  Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients.

Authors:  Toshko Lissitchkov; Bella Madan; Claudia Djambas Khayat; Nadezhda Zozulya; Cecil Ross; Mehran Karimi; Kaan Kavakli; Guillermo R De Angulo; Abdulkareem Almomen; Kannan Subramanian; Fulton D'Souza; Auro Viswabandya; Hamid Hoorfar; Bruce A Schwartz; Cristina Solomon; Sigurd Knaub; Flora Peyvandi
Journal:  J Thromb Haemost       Date:  2020-01-21       Impact factor: 5.824

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.